Company / Capital Expenditures
BioAge Labs, Inc. Capital Expenditures History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$719.0K
FY2025
5-year range
$166.0K / $719.0K
FY2023-FY2025
Trend
+96.4%
vs FY2024
Sector context
#125 of 194
Health Care
What the data says
At $719,000, BioAge Labs, Inc.'s capital expenditures ranks #125 of 194 in the Health Care sector. Improved from $166,000 to $719,000 over the past 2 years.
Based on SEC 10-K filings.
$719,000 in FY2025.
Improved from $166,000 to $719,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#125 of 194 in Health CareTop 64% of 194This company $719.0K Sector average $117.5M
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, capital expenditures increased 96.4% year-over-year.
- Ranks #125 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $719.0K | +96.4% |
| FY2024 | $366.0K | +120.5% |
| FY2023 | $166.0K | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026